| Autor: |
Bhattacharyya, Anamika, Sadhasivam, Suresh, Sinha, Mau, Gupta, Swati, Saini, Swamini, Singh, Himanshi, Khurana, Ananta, Sachdeva, Soumya, Sardana, Kabir, Ghosh, Shamik |
| Předmět: |
|
| Zdroj: |
International Journal of Dermatology; May2023, Vol. 62 Issue 5, p637-648, 12p |
| Abstrakt: |
Background: Recalcitrant dermatophyte infections are being reported from various parts of the world due to varied causes including strain variation, steroid misuse, SQLE mutations, and variable quality of itraconazole pellet formulations. The oral drug preferred in endemic areas is itraconazole, to which MIC levels remain low, and clinical failures to itraconazole reported defy a sound scientific explanation. Objectives: The objective of the study was to conduct a proteomic and genomic analysis on isolates from therapeutically recalcitrant case with isolation of gene mutations and enzymatic abnormalities to explain azole failures. Methods: Trichophyton mentagrophyte interdigitale complex strains were isolated from seven clinically non‐responding tinea corporis/cruris patients, who had failed a sequential course of 6 weeks of terbinafine 250 mg QD and itraconazole 100 mg BID. After AFST 1 strain, KA01 with high MIC to most drugs was characterized using whole genome sequencing, comparative proteomic profiling, and total sterol quantification. Results: Sterol quantification showed that the standard strain of Trichophyton mentagrophytes (MTCC‐7687) had half the ergosterol content than the resistant KA01 strain. Genomic analysis revealed mutations in SQLE, ERG4, ERG11, MDR1, MFS genes, and a novel ERG3 mutation. Proteomic analysis established the aberrant expression of acetyl Co‐A transferase in the resistant strain and upregulation of thioredoxin reductase and peroxiredoxin. Conclusion: Our findings demonstrate possible reasons for multidrug resistance in the prevalent strain with mutations in genes that predict terbinafine (SQLE) and azole actions (ERG4, ERG11, ERG3) apart from efflux pumps (MDR1, MFS) that can explain multidrug clinical failures. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text